200 related articles for article (PubMed ID: 21441823)
21. Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis.
Al-Aly Z; Pan H; Zeringue A; Xian H; McDonald JR; El-Achkar TM; Eisen S
Transl Res; 2011 Jan; 157(1):10-8. PubMed ID: 21146146
[TBL] [Abstract][Full Text] [Related]
22. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
[TBL] [Abstract][Full Text] [Related]
23. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
24. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
Liang GC; Cordero M; Dyer A; Chang RW
J Rheumatol; 2005 Sep; 32(9):1662-5. PubMed ID: 16142857
[TBL] [Abstract][Full Text] [Related]
25. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.
Setoguchi S; Solomon DH; Weinblatt ME; Katz JN; Avorn J; Glynn RJ; Cook EF; Carney G; Schneeweiss S
Arthritis Rheum; 2006 Sep; 54(9):2757-64. PubMed ID: 16947774
[TBL] [Abstract][Full Text] [Related]
27. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
28. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
29. Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis.
Wu CL; Chang CC; Kor CT; Yang TH; Chiu PF; Tarng DC; Hsu CC
Clin J Am Soc Nephrol; 2018 May; 13(5):702-709. PubMed ID: 29661770
[TBL] [Abstract][Full Text] [Related]
30. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
31. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women.
Villegas R; Liu S; Gao YT; Yang G; Li H; Zheng W; Shu XO
Arch Intern Med; 2007 Nov; 167(21):2310-6. PubMed ID: 18039989
[TBL] [Abstract][Full Text] [Related]
35. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
36. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
37. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
[TBL] [Abstract][Full Text] [Related]
39. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]